SAB BIOTHERAPEUTICS, INC. (SABSW) Free cash flow 2020–2025
SAB BIOTHERAPEUTICS, INC. (SABSW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$45.7MFY2025 · since FY2020: -$2.7M → -$45.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$45.7M | -32.0% |
| FY2024 | -$34.6M | -36.8% |
| FY2023 | -$25.3M | +1.2% |
| FY2022 | -$25.6M | -186.1% |
| FY2021 | -$9.0M | -228.5% |
| FY2020 | -$2.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice